Glenmark Pharma Q1 Results | Net profit plunges 86% to ₹47 crore despite stable revenue
EBITDA dipped 1.4% to ₹580 crore in the first quarter compared to ₹588.2 crore a year ago. The EBITDA margin was lower at 17.7% versus 18.1% in Q1FY25. Shares of Glenmark Pharmaceuticals Ltd ended at ₹2,038.95, up by ₹7.15 or 0.35%, on the BSE today (August 14).
EBITDA dipped 1.4% to ₹580 crore in the first quarter compared to ₹588.2 crore a year ago. The EBITDA margin was lower at 17.7% versus 18.1% in Q1FY25. Shares of Glenmark Pharmaceuticals Ltd ended at ₹2,038.95, up by ₹7.15 or 0.35%, on the BSE today (August 14).
What's Your Reaction?
FEDA-HQ
The Federation of Economic Development Association of India (F.E.D.A) holds the distinction of being India's most venerable umbrella organization. F.E.D.A focused on promoting economic growth in India. Economic development professionals throughout the state, along with individuals and companies in related economic development fields, work together with the F.E.D.A Members and Board of Federation to help positively influence country legislation and industrial growth. With cutting edge policy research and advisory to National and State governments on trade issues. F.E.D.A is one of the leading non-profit organizations with established credentials for enhancing economic development.
